Laura Escudero, Cardiff University, UK
We are living in difficult times of change and instability, where terrorism, division and isolation of nations are a reality. However, these past four days I was taught some important lessons: one of unity, collaboration and the will to help others.
Scientists from around the world gathered together at the 24th biannual meeting of the European Association for Cancer Research from 9th-12th July in Manchester, UK. The meeting was a success: 1470 researchers from 61 countries were welcomed at EACR24. The content of the talks and poster presentations was intellectually stimulating and were delivered with the highest quality. There were plenty of opportunities for interaction, meeting new people and setting up new collaborations.
Scientists are famous for being unsociable and independent but the reality is completely different. We all come from different places and cultures. We all have different occupations: mathematicians, bioinformaticians, physicists, biologists, chemists and clinicians but we pursue the same goal: cure cancer.
Cancer affects everyone in the world, directly or indirectly, and it does not discriminate. Similar to our world, cancer is not static, it is dynamic and evolves. There isn’t just one universal solution, and scientists know that the key to success is UNITY. Only together we will cure cancer. Together, we are stronger.
I feel proud to belong to a community where everyone is respected and can learn from each other. A community that asks questions, listens and respects the opinions of others. No matter how young or senior, where you come from, we work towards the same goal: cure cancer.
I have learnt the importance of being part of a great organisation such as the EACR. They facilitated, coordinated and organised the conference that enable us to gather together, share information and establish collaborations. This way we can tackle the problem from different angles and be a step closer to success.
For all this, I am sincerely grateful to the EACR for the meeting bursary that allowed me to be part of this fantastic conference. I learnt a lot and it taught me important lessons that I want everyone who suffers from cancer to know: one of unity, collaboration and the will to help others.
Manuel-Pedro JiménezGarcía, Biomedicine Institute of Seville, Spain
The main reason I wanted to attend and actively participate into EACR24 was to take an active role in scientific community, bringing discoveries in molecular oncology area, and strengthening of ties both with top molecular oncology researchers and other PhD students. Therefore, the attending to EACR24 Congress allowed me to acquire the scientific world’s machinery knowledge and also to supplement my theoretical and practical training in all topics proposed at conferences, related to my PhD thesis which they are: the mechanisms of drug resistance joined to signaling pathway that would be linked to genes that I am currently characterizing in human sarcoma models, in order to decode their relationship to the maintenance of stem cell populations, which lead to high relapse rate in human sarcoma and it has significant clinical interest.
To sum up, I consider EACR24 congress as a positive outcome both professional and personal. I am convinced EACR24 has established as a decisive experience in my scientific life and will mark an evolution process in the course of my PhD and everything that will come next.
Erika Larrea de Orte, Biodonostia Research Institute, Spain
Attending EACR24 conference has been a very exciting and interesting experience. It gave me the opportunity to attend great and inspiring talks and also to meet some researchers working in the same area as me so we could discuss about our research projects in particular during the poster sessions. Also, I could recognize and share time with people from a previous EACR conference in Cambridge and also with new young researchers I met in this conference. In general I found the whole experience very enriching and helpful to see my phD project with more perspective and open my mind to new ideas and approaches.
Oleg Tutanov, Institute of Chemical Biology and Fundamental Medicine, Russia
I was very pleased with getting an EACR Meeting Travel Bursary to attend EACR24 Congress. My current PhD work is revolving around exosomes and nucleoprotein complexes circulating in blood of healthy females and breast cancer patients. I seek for knowledge of their protein and RNA content in context of their role in healthy organism and during the development of malignancy. The congress for me was a great opportunity in several ways: I was able to present a discus my current work with colleagues from all over the world with the different backgrounds: from fundamental biology/biochemistry to medicine through translational research. Moreover I went through different research works presented in oral and poster sessions, met some great professionals in several fields. I really want to highlight the level of the congress – I was overwhelmed with high number of amazing talks, astonishing exhibiting companies’ booths and brilliant friendly and helpful people in the organization of the congress itself. The only thing I would add to the congress is the length of Young Cancer Researchers Workshops, it was interesting and insightful and I wanted to take part in more topics that I was able to. I also want to highlight the overall friendliness of the EACR themselves, being the part of EACR General Assembly was a great experience and I felt coziness throughout the whole congress. I am very grateful for this opportunity and it would not be possible for me to attend an event of such a scale without the help of EACR.
Bursary Application deadline
14 February 2018
Abstract Submission deadline
28 February 2018
Early registration rate
15 March 2018
Regular registration rate
14 May 2018
Late registration rate
22 June 2018
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.